XML 180 R103.htm IDEA: XBRL DOCUMENT v3.26.1
Discontinued operations - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure of analysis of single amount of discontinued operations [line items]      
Revenue $ 92,390 $ 15,936 $ 6,155
Loss from discontinued operations 3,731 11,420 21,779
Profit (loss) from discontinued operations (3,173) (7,086) (20,155)
(Loss) profit attributable to non-controlling interests from continuing operations attributable to non-controlling interests (558) (4,334) (1,624)
Comprehensive income (loss) from continuing operations, attributable to owners of parent (34,169) (39,045) (41,493)
Discontinued operations      
Disclosure of analysis of single amount of discontinued operations [line items]      
Revenue 9,605 14,782 29,050
Discontinued operations | Diagnostics - sale of precision oncology services      
Disclosure of analysis of single amount of discontinued operations [line items]      
Revenue 9,605 14,685 15,588
Discontinued operations | Diagnostics sale of precision oncology services, adjusted loss from discontinued operations, net of tax      
Disclosure of analysis of single amount of discontinued operations [line items]      
Loss from discontinued operations 1,419 8,452 20,281
Total for all related parties | Discontinued operations | Diagnostics - sale of precision oncology services      
Disclosure of analysis of single amount of discontinued operations [line items]      
Revenue $ 2,312 $ 2,968 $ 1,498